This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Masarykova Univerzita. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Pavlina Janovska: Innovator in Cancer Treatment
Introduction
Pavlina Janovska is a notable inventor based in Brno, Czech Republic. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. Her work focuses on addressing critical health challenges, particularly in the treatment of various types of cancers.
Latest Patents
Pavlina Janovska holds a patent for her invention titled "4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridines for use in the treatment of leukaemias, lymphomas and solid tumors." This patent encompasses novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds that are useful in the treatment of lymphomas, leukaemias, and solid tumors. She has successfully developed 1 patent that showcases her commitment to advancing medical science.
Career Highlights
Pavlina Janovska is affiliated with Masaryk University, where she conducts her research and collaborates with other experts in the field. Her academic background and dedication to innovation have positioned her as a key figure in cancer research.
Collaborations
Throughout her career, Pavlina has worked alongside talented colleagues, including Vitezslav Bryja and Michaela Gregorova. These collaborations have enriched her research and contributed to the development of effective cancer treatments.
Conclusion
Pavlina Janovska's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her dedication to research and development continues to inspire advancements that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile